Tomer Stavitsky

Tomer Stavitsky is a seasoned professional in the fields of corporate development and business development, currently serving as the Head of Business Development for the US at Sweetch, focusing on chronic disease management in obesity and diabetes. Additional roles include Strategic Partnerships Executive at Ceevra, Inc., where Tomer manages partnerships in AI-driven 3D imaging, and as an Executive Corporate Development Advisor at Tomer Stavitsky Consulting & Advisory, providing guidance to MedTech and Digital Health companies. Tomer is also involved in mentoring at Alchemist Accelerator and contributes to Fractionals United and the International LEAP Network. Previous experience includes significant leadership roles at Allurion Technologies, Ginkgo Bioworks, and Intuitive Surgical, emphasizing expertise in mergers and acquisitions, corporate strategy, and digital health initiatives. Tomer Stavitsky holds an MBA in Corporate Finance & Entrepreneurship from UNC Kenan-Flagler Business School and a BA in Business Administration from The College of Management Academic Studies.